In a lawsuit filed yesterday, MIT and Children's Hospital charge Shire Regenerative Medicine's product aimed at people with diabetic foot ulcers violates patents they hold for building skin grafts on a polyester matrix.
The two local institutions say Shire's Dermagraft, in which cells from newborn foreskins are laid on a thin membrane to grow a layer of skin that are then applied atop the ulcers that some diabetic patients develop on their feet.
They're seeking tons of money for the injuries the alleged patent infrigement has done them.
In the Boston Store:
The great blizzard of 1978 is an event seared in the memory of anyone who lived through it. Most of...
$18.75 - Learn more / Buy
When terrorists apparently strike one of Boston's Mbta transit stations during the famed St....
$25.99 - Learn more / Buy
There is nothing imaginary about Junger's book; it is all terrifyingly, awesomely real...
$12.13 - Learn more / Buy